Safety of lumbar puncture in adult patients with acute lymphoblastic leukemia and thrombocytopenia: A retrospective study

Abstract Introduction: Acute lymphoblastic leukemia (ALL) requires lumbar punctures (LPs) for central nervous system (CNS) diagnosis and treatment. Guidelines suggest a platelet threshold of ≥50×10⁹/L; however, patients often present with thrombocytopenia. Evidence on the safety of performing LPs with low platelet counts in adults is limited. Objective: To evaluate the association between thrombocytopenia and adverse events (AEs) following LP in adults with ALL. Methods: Retrospective study conducted at the Instituto Nacional de Cancerología (Mexico, 2017–2023). We included 185 adult ALL patients, totaling 442 LPs. LPs were categorized by pre-procedure platelet count: ≥100×10⁹/L, 50–99×10⁹/L, and <50×10⁹/L. Hemorrhagic events, traumatic LPs, headache, and other AEs were assessed. Statistical tests compared groups. Results: Median age was 33.7 years; 68.6% were young adults. 93.5% had B-cell ALL, and 17.8% had CNS involvement. 72.4% had thrombocytopenia at diagnosis, with 30.8% having <20×10⁹/L. Overall, 13 hemorrhagic events (2.9%) were identified, with no significant difference between platelet groups (*p*=0.7891). A total of 46 LP-associated AEs (10.4%) were recorded, primarily headache (9.2%), puncture-site bleeding, subdural hematoma, and seizures. AE incidence was higher in thrombocytopenic groups (*p*=0.003), though grade III–IV events were rare (*n*=2) and not significantly different (*p*=0.8074). Traumatic LP rates were similar across platelet categories (*p*=0.9473). Prophylactic transfusion practices varied. Among patients with <50×10⁹/L, 79 transfusions were administered, with no significant differences in headache or puncture-site bleeding between transfused and non-transfused patients (*p*>0.4). One subdural hematoma occurred in a transfused patient. Conclusions: In our study, thrombocytopenia <50×10⁹/L was not associated with increased risk of severe bleeding or traumatic LP. However, the optimal safety threshold remains uncertain, with emerging literature suggesting ≥30×10⁹/L. Operator skill may be a key factor in procedural safety. Multicenter prospective studies are needed to establish optimal thresholds.

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-1559
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of lumbar puncture in adult patients with acute lymphoblastic leukemia and thrombocytopenia: A retrospective study

Omar Fernández Vargas, A. Salcedo, María E. Rodríguez, Marco Franco
Blood
Venous Thromboembolism Diagnosis and Management
article

Safety of lumbar puncture in adult patients with acute lymphoblastic leukemia and thrombocytopenia: A retrospective study

Omar Fernández Vargas, A. Salcedo, María E. Rodríguez, Marco Franco
article en

Abstract

Abstract Introduction: Acute lymphoblastic leukemia (ALL) requires lumbar punctures (LPs) for central nervous system (CNS) diagnosis and treatment. Guidelines suggest a platelet threshold of ≥50×10⁹/L; however, patients often present with thrombocytopenia. Evidence on the safety of performing LPs with low platelet counts in adults is limited. Objective: To evaluate the association between thrombocytopenia and adverse events (AEs) following LP in adults with ALL. Methods: Retrospective study conducted at the Instituto Nacional de Cancerología (Mexico, 2017–2023). We included 185 adult ALL patients, totaling 442 LPs. LPs were categorized by pre-procedure platelet count: ≥100×10⁹/L, 50–99×10⁹/L, and <50×10⁹/L. Hemorrhagic events, traumatic LPs, headache, and other AEs were assessed. Statistical tests compared groups. Results: Median age was 33.7 years; 68.6% were young adults. 93.5% had B-cell ALL, and 17.8% had CNS involvement. 72.4% had thrombocytopenia at diagnosis, with 30.8% having <20×10⁹/L. Overall, 13 hemorrhagic events (2.9%) were identified, with no significant difference between platelet groups (*p*=0.7891). A total of 46 LP-associated AEs (10.4%) were recorded, primarily headache (9.2%), puncture-site bleeding, subdural hematoma, and seizures. AE incidence was higher in thrombocytopenic groups (*p*=0.003), though grade III–IV events were rare (*n*=2) and not significantly different (*p*=0.8074). Traumatic LP rates were similar across platelet categories (*p*=0.9473). Prophylactic transfusion practices varied. Among patients with <50×10⁹/L, 79 transfusions were administered, with no significant differences in headache or puncture-site bleeding between transfused and non-transfused patients (*p*>0.4). One subdural hematoma occurred in a transfused patient. Conclusions: In our study, thrombocytopenia <50×10⁹/L was not associated with increased risk of severe bleeding or traumatic LP. However, the optimal safety threshold remains uncertain, with emerging literature suggesting ≥30×10⁹/L. Operator skill may be a key factor in procedural safety. Multicenter prospective studies are needed to establish optimal thresholds.

BloodVol. 146(Supplement 1)
National Cancer Institute (UA), National Cancer Institute (MY), Instituto Nacional de Cancerología (MX)
Openalex Percentile: Top 41%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.